Literature DB >> 15201367

Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease.

Y Wakutani1, K Watanabe, Y Adachi, K Wada-Isoe, K Urakami, H Ninomiya, T C Saido, T Hashimoto, T Iwatsubo, K Nakashima.   

Abstract

OBJECTIVE: To describe a novel missense mutation, Asp678Asn (D678N), in the amyloid precursor protein (APP) gene in a Japanese pedigree of probable familial Alzheimer's disease (FAD). SUBJECT: The proband was a women of 72. Symptoms of dementia that fulfilled the criteria for probable Alzheimer's disease appeared at about 60 years of age, and slowly worsened over more than 10 years without evident cerebrovascular complications, either clinically or neuroradiologically.
METHODS: Polymerase chain reaction single strand conformational polymorphism (PCR-SSCP) analysis followed by sequence analysis was used to examine genomic DNA of the proband for mutations in the APP gene exons 16 and 17.
RESULTS: Analysis of the APP exon 16 in the proband showed a GAC to AAC nucleotide substitution in codon 678 of the APP gene, causing an amino acid substitution of Asp to Asn (D678N). Heterozygosity of the APP D678N mutation was found in the proband and in the demented elder sister.
CONCLUSIONS: The production and accumulation of mutated Abeta (Asn7-Abeta) or the misfunction of D678N mutant APP may have pathogenic properties for the development of Alzheimer's disease in this pedigree.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201367      PMCID: PMC1739111          DOI: 10.1136/jnnp.2003.010611

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.

Authors:  Kenjiro Ono; Margaret M Condron; David B Teplow
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42.

Authors:  Man Hoang Viet; Phuong H Nguyen; Son Tung Ngo; Mai Suan Li; Philippe Derreumaux
Journal:  ACS Chem Neurosci       Date:  2013-09-16       Impact factor: 4.418

4.  Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.

Authors:  Nadezda P Sargaeva; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2009-12-01       Impact factor: 6.986

5.  Presenilin-2 gene mutation presenting as Lewy body dementia?

Authors:  Loredana Raciti; Alessandra Nicoletti; Francesco Le Pira; Virginia Andreoli; Donatella Contrafatto; Salvatore Lanzafame; Tiziana Maci; Antonio Gambardella; Aldo Quattrone; Mario Zappia
Journal:  Neurol Sci       Date:  2011-03-16       Impact factor: 3.307

Review 6.  Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.

Authors:  Jorge Ghiso; Silvia Fossati; Agueda Rostagno
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

8.  The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.

Authors:  Orkid Coskuner; Olivia Wise-Scira; George Perry; Taizo Kitahara
Journal:  ACS Chem Neurosci       Date:  2012-12-18       Impact factor: 4.418

9.  Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity.

Authors:  Huiyuan Li; Bernhard H Monien; Erica A Fradinger; Brigita Urbanc; Gal Bitan
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

Review 10.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.